
Remedee Labs
Remedee Labs offers a non-invasive neuromodulation device that utilizes millimeter-wave technology to stimulate peripheral nerves, promoting the release of endorphins for pain relief. This solution addresses the needs of the 12 million individuals in France suffering from chronic pain, many of whom do not receive adequate treatment from existing therapies.
- Digital Health
- Hardware
- Healthcare Technology
- Medical Devices
Funding
Raised to date
$30.2MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.



Founders
Founder details are not available yet.
Product
Problem
Chronic pain affects millions, with a significant portion not finding adequate relief from existing treatments. This unmet need leads to a diminished quality of life for those affected.
Solution
Remedee Labs offers a non-invasive solution for chronic pain management using millimeter-wave technology to stimulate peripheral nerves and trigger the release of endorphins. The core of the solution is a wearable device that delivers targeted neuromodulation. This technology is coupled with a digital platform that provides personalized support and remote coaching, creating a comprehensive and patient-centric approach to pain relief. Clinical studies have demonstrated the effectiveness of this approach in reducing pain and improving the quality of life for individuals with conditions like osteoarthritis and fibromyalgia.
Target Audience
The primary target audience includes individuals suffering from chronic pain conditions such as osteoarthritis and fibromyalgia, as well as healthcare professionals seeking non-pharmacological pain management solutions.
Features
- Wearable device utilizing millimeter-wave technology for peripheral nerve stimulation
- Personalized digital platform for remote coaching and support
- Mobile application for tracking sessions, symptoms, and progress
- Non-pharmacological approach targeting the body's natural endorphin production
- Clinically validated for pain reduction and improved quality of life in osteoarthritis and fibromyalgia patients